Filter Reset
General practitioner

Efficacy of moxifloxacin in the treatment of communityacquired pneumonia

The review article presents the results of domestic and international studies of the use of fluoroquinolone 4th generation Moxifloxacin in the treatment of community-acquired pneumonia and pneumonia caused by SARS-CoV-2. Analysis of the clinical use of moxifloxacin in the treatment of infectious complications of the respiratory tract indicates its high efficiency and bioavailability, low risk...